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1. Introduction
Prostate cancer has been reported with a high incidence of 7.9%, 
representing the fourth leading cancer in the general population, 
according to the International Agency for Research on Cancer 
(IARC) of the World Health Organization released (WHO) in 
2014 [1].  In a more recent report, 26% of newly diagnosed cases 
of cancer in the United States and 9% of men’s deaths are related 
to prostate cancer [2].  In other reports, the incidence rates of 
prostate cancer are different in different Asian countries, ranging 
from low incidence (2/100,000 population in Iran) to high inci-
dence (20/100,000 population in the Philippines).  In Iran, pros-
tate cancer is one of the most common cancers among men, with 
the highest prevalence in Tehran (41.2%) and comparatively low-
er prevalence in other large and industrial provinces (36.8%), and 
small towns and villages (22.1%) [3-8].  These reports suggest 
that prostate cancer is one of the most common causes of mortal-
ity in men, comprising an important health issue, which makes 
its treatment essential.  However, despite the many treatments for 
prostate cancer, due to drug resistance, several complications of 
used medications and treatments, the available treatment options 
have not been able to reduce the survival rates of prostate cancer 
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ABSTRACT
Background: Prostate cancer has been known as one of the most common malignancy in the men and it is 
therefore very important to prevent and treat this cancer.  In this study, the anticancer effects of 20 species of 
medicinal plants in Iran, especially those grown in Chaharmahal and Bakhtiari province, were investigated 
on prostate cancer cell lines to identify potential natural alternatives for the development of prostate cancer 
anticancer drugs.
Methods: The plants were gathered from Chaharmahal va Bakhtyari and their aerial parts extracted through 
maceration method using ethanol 70%.  Anti-proliferative activity of extracts on PC-3, DU145 and HDF cell 
lines was evaluated by MTT assay 48 hours after treatment. 
Results: Euphorbia szovitsii Fisch. & C.A.Mey. and Achillea wilhelmsii had anti-proliferative activity more 
than other plants on PC-3.  Also IC50s for Urtica dioica, Euphorbia szovitsii Fisch. & C.A.Mey. and Medi-
cago sativa were lower amount among the examined plants on Du-145. 
Conclusion: According to our result, Euphorbia szovitsii Fisch. & C.A.Mey., U. dioica and Medicago sativa 
with good anti-proliferative activity can serve as an effective source of natural products to develop new anti-
prostate cancer drugs.
patients and the survival rates remain far less-than-optimal [9-12].
Given the treatments that are currently being used to fight 
prostate cancer and associated complications, drug resistance 
especially in metastatic prostate cancers, ever-increasing costs 
of common treatments, and the increasing incidence of prostate 
cancer in both developing and developed countries, it is necessary 
to discover newer therapeutic approaches with higher efficacy 
to reduce the incidence and mortality of prostate cancer.  In this 
regard, it is necessary to find cytotoxic plants against various can-
cers, especially prostate cancer, which, despite lower side effects, 
can replace chemotherapy and difficult treatments, and also be 
used for treatment-resistant cases [13-17].  These plants have high 
levels of phytochemicals that will have many therapeutic effects 
[18, 19].  Iran especially Chaharmahal and Bakhtiari province 
is rich in medicinal plants and many medicinal plants are found 
only in these areas and are native to these regions and the climatic 
conditions of these areas have caused these plants to contain high 
concentrations of phytochemical compounds with various thera-
peutic effects.
Taken together, our aim was to investigate certain species of 
medicinal plants in Iran, especially those growing in Chaharma-
hal va Bakhtiari province in Iran, whose effects have not yet been 
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immunosorbent assay (ELISA) reader.
The percentage of inhibition was measured as [1- (optical 
density of test/ optical density of negative control)] × 100.  The 
IC50 val ue (the concentration with 50% cell inhibition) was 
calcu lated via the graph of inhibition percentage versus different 
extract concentrations.
2.5. Statistical analysis
The dose-response curves of the plants were fitted by means of 
the computer program GraphPad Prism 6.0 (GraphPad Software, 
USA), and IC50 was defined by regression analysis.
3. Results
In this study, 20 species of Iranian medicinal plants were inves-
tigated.  The most of the plants were from Lamiaceae family 
(Table 1).
Anticancer activity (IC50) of the 20 medicinal plants on 
DU-145 and PC-3 has been shown in tables 2.  Extracts with 
IC50>300 μg/ml in MTT assay were considered inactive.
Euphorbia szovitsii Fisch. & C.A.Mey. (Fig. 1a) had the best 
anticancer effect on PC-3 compared other investigated medici-
nal plants.  Also IC50s for Urtica dioica (Fig. 1b), Euphorbia 
szovitsii Fisch. & C.A.Mey. and Medicago sativa (Fig. 1c) were 
lower amount among the examined plants on Du-145.
For investigating the cytotoxicity effect of medicinal plants 
gathered from Chaharmahal va Bakhtiari province on normal 
cells we investigated the effect of ethanolic extract of effective 
medicinal plants on HDF cell line (Table 3).  In IC50 concentra-
tion, Urtica dioica. and Euphorbia szovitsii Fisch. & C.A.Mey. 
don’t have any effects on HDF cells.
4. Discussion
According to the results of studies and also the report of IARC of 
the WHO in 2014 [6], despite extensive studies on the discovery 
of anticancer drugs, the incidence and prevalence of various can-
cers remain high and in many cases, drug resistance leads to lack 
of appropriate response; therefore, it is essential to conduct fur-
ther studies and discover drugs with more potent effects that can 
serve as alternatives to chemical drugs and reduce the side effects 
of current medications and therapies.  Phytotherapy is one of the 
approaches that have been used to treat various cancers in recent 
years [13-17].  In this regard, the present study was carried out to 
screen medicinal plant species in Iran, especially Chaharmahal 
and Bakhtiari province, on prostate cancer cell lines. Of the stud-
ied 20 plant species, Euphorbia szovitsii fisch & C.A.Mey and 
Achillea wilhelmsii exerted relatively higher anticancer effects on 
the PC-3 cell line and Urtica dioica, Euphorbia szovitsii Fisch. & 
C.A.Mey and Medicago sativa exerted comparatively more potent 
anticancer effects on the DU-145 cell line.
So far, the preventive and anticancer effects of many medici-
nal plants, as well as the effects of their derivatives on different 
cell lines, have been studied.  In a review (2015), the effects of 
34 Iranian medicinal plants tested for their anticancer effects on 
different cell lines and with animals and human subjects were re-
ported [23].  U. dioica, which has been investigated for its effect 
on prostate cancer cell lines including LNCaP and hPCPs, is one 
of the plants in Iran whose effects on some prostate cancer cell 
lines have been studied [24].  In our study, the effect of this plant 
studied on prostate cancer cell lines but they are used as antican-
cer agents according to public beliefs and Iranian traditional med-
icine books, or whose anti-inflammatory and antioxidant effects 
were confirmed in studies so that they may be used to produce 
more efficient and  novel drugs to treat prostate cancer.
2. Material and methods
2.1. Plant material
The plants were collected locally in different points of Chaharma-
hal va Bakhtiari province in Iran in May-Sep 2015 and botanically 
authenticated by Dr. Shirmardi (Research Center for Agricultural 
& Natural Resources, Shahrekord, Iran) and Miss S. Khademian 
(Department of Pharmacognosy, Faculty of Pharmacy, Shiraz 
University of Medical Sciences).  Stachys inflate, Salvia multi-
caulis Vahl, Hertia angustifolia, Sophora alopecuroides, Haplo-
phyllum perforatum, Moriera spinosa Boiss., Teucrium orientale 
L. subsp. taylori. (Boiss.), Achillea wilhelmsii, Urtica dioica, 
Plantago lanceolata, Euphorbia microsciadia Boiss., Medicago 
sativa, Satureja bachtiarica, Acanthophyllum glandulosum Bung. 
ex Boiss, Onosma sericeum, Parietaria judaica, Phlomis persica, 
Ziziphora clinopodioides, Echinophora platyloba D.C, and Eu-
phorbia szovitsii Fisch. & C.A.Mey included in this study.
2.2. Preparation of extracts
The herbal samples were cleaned, shade dried in, pulverized to 
powder in a mechanical grinder and mac erated in ethanol (70%) 
at room temperature for 72 hours.  In the next step, the hydro al-
coholic extracts were concentrated by a rotary evaporator under 
re duced pressure. Samples were dissolved in DMSO % 0.1 (dim-
ethyl sulfoxide, Sigma) [20-23].  Finally, extracts were diluted in 
RPMI 1640 at con centration of 5 mg/ml.
2.3. Cell lines and culture medium
The following cancer cell lines were used for this study: PC-3 
and DU145 (prostate cancer cell lines) and HDF (Human Dermal 
Fibroblasts) as non-cancer cell line.  Cells were obtained from 
National Cell Bank of Iran (Pasteur Institute, Tehran, Iran).
Cells were cultured in RPMI1640 (Roswell Park Memorial 
Institute medium 1640; Gibco) with 1% penicillin-streptomycin 
and 10% FBS (Sigma) in a humidified atmosphere with 5% Co2 
at 37°C throughout the assay.
2.4. Antiproliferative assay
3-[4, 5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide 
assay (MTT assay) was used for evaluating cell viability.  The 
cells (PC-3, DU145, and HDF) cells were seeded in 96-well 
plates and incubated at 37°C.  After 24 h of incubation, when 
cells reached more than 80-90% confluence, the medium was 
removed and the cells were treated with fresh medium contain-
ing various concentrations of plant extracts to be tested (10 µg/
ml-1 mg/ml).  After 48 h, the supernatant liquids were eliminated 
and a medium including MTT solution (0.5 mg/ml) was added to 
the wells which were incubated for 4 h.  In the next step, supple-
ments were eliminated, and the formazan crystals were dissolved 
in DMSO.  The absorbance of the plates were determined at 570 
nm with a reference wavelength of 630 nm in an enzyme linked 
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on the other two cell lines of prostate cancer, i.e. PC-3 and DU-
145, was investigated.  A study (2014) showed that the cytotoxic 
effect of aqueous U. dioica extract on LNCaP cell line is mediated 
by apoptosis and oxidative stress [25].  Aqueous U. dioica extract 
results in significant inhibition of adenosine deaminase (ADA) 
activity in prostate tissue [26].
Medicago sativa, as one of the other plants in our study, has 
good anti-proliferative activity on DU-145 cell line.  In the previ-
ous study, anticancer effect of M. sativa on multidrug-resistant 
tumor cells lines has been reported.  M. sativa could induce apop-
tosis in these cells lines [27].  Also some of isolated compounds 
from M. sativa have been indicated to have antitumor activity 
against different cancer cell lines such as leukemia, cervix and 
breast cancer [28, 29].  The results of present study and other 
studies that have examined the effect of U. dioica and M. sativa 
on cancers suggest them as effective medicinal plants in the pre-
vention and treatment of cancers.
Thymus vulgaris, Taverniera spartea, Camellia sinensis, 
Ferula gummosa, Allium sativum, Curcuma longa and Zingiber 
officinale are other species in Iran, which are similar to the stud-
ied plants studied in the current work in terms of plant families 
or chemical compounds, and their anticancer effects on prostate 
cancer have also been investigated [30-35].  However, according 
to the available results, none of the plant species in Iran have yet 
been studied for their effects on prostate cancer cell lines (DU-145 
and PC-3).
In the present study, Euphorbia szovitsii Fisch. & C.A.Mey, 
that is a species of the Euphorbia genus, was found to have better 
antitumoural effects on both prostate cancer cell lines than other 
plants under study.  The plants from the Euphorbia genus have 
traditionally been used to treat inflammation and tumors [36, 
37].  Besides that, cytotoxic and immunosuppressive effects have 
Table 1 − Screened medicinal plants in this study.
No. Scientific names Persian name Family Herbarium code
  1 Salvia multicaulis Vahl Gol arvaneh Lamiaceae Skums-301
  2 Stachys inflate Sonbole badkonaki Lamiaceae Skums-260
  3 Teucrium orientale L. subsp. taylori. (Boiss.) Maryam nokhodi sharghi Shirazi Lamiaceae Skums-522
  4 Satureja bachtiarica Marzeh Bakhtiyari Lamiaceae Skums-208
  5 Phlomis persica Goshbareh Irani Lamiaceae Skums-700
  6 Ziziphora clinopodioides Kakoti kohi Lamiaceae Skums-253
  7 Hertia angustifolia Karghich Asteraceae Skums-701
  8 Achillea wilhelmsii Bomadaran Asteraceae Skums-207
  9 Euphorbia microsciadia Boiss. Farfion Euphorbiaceae Skums-659
10 Euphorbia szovitsii Fisch. & C.A.Mey. Farfion Euphorbiaceae Skums-935
11 Sophora alopecuroides Talkhbayan Fabaceae Skums-258
12 Medicago sativa Yonjeh Fabaceae Skums-742
13 Haplophyllum perforatum Morde kazeb Rutaceae Skums-150
14 Moriera spinosa Boiss. Kharmarjan Brassicaceae Skums-623
15 Urtica dioica Gazaneh Urticaceae Skums-303
16 Plantago lanceolata Kardi (Barhang sarneyzei) Plantaginaceae Skums-252
17 Acanthophyllum glandulosum   Bung. ex Boiss Chobak nekaei Caryophyllaceae Skums-896
18 Onosma sericeum Gavzaban Boraginaceae Skums-841
19 Parietaria judaica Goshmosh Urticaceae Skums-617
20 Echinophora platyloba D.C Khosharozeh Apiaceae Skums-249
Fig. 1 - Pictures of more effective plants.
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been reported for the hydroalcoholic extracts of other species of 
the Euphorbia genus. In addition, in recent studies, the anticancer 
effects of other plants of the Euphorbia genus and also their com-
pounds, have been reported specifically on various cancer cell 
lines, suggesting that the plants of this genus have an acceptable 
anti-cancer potential [38-45].  The results of our study are in line 
with these studies and Euphorbia szovitsii Fisch. & C.A.Mey has 
an acceptable potential for anticancer effects on prostate cancer.
5. Conclusion
According to our results, E. szovitsii Fisch. & C.A.Mey. with 
good anti-proliferative activity on both prostate cancer cell lines 
and U. dioica and M. sativa with good anti-proliferative activity 
on DU-145 cell line can serve as an effective source of natural 
products to develop new anti-prostate cancer drugs.
Conflicts of interest statement
The authors declare no conflict of interest.
Acknowledgments
This study has been extracted from the PhD thesis of Majid 
Asadi-Samani.  Shahrekord University of Medical Sciences has 
Table 3 − Cell viability of the ethanolic extract of effective medicinal plants gathered from Chaharmahal 
va Bakhtiari province on HDF.
Scientific names IC50 (µg/ml) 95% Confidence Intervals R
Medicago sativa   448 382-526 0.9676
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